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ABSTRACT  MDW40, a wheat germ agglutinin-resistant (WGA r) mutant of the highly metastatic 
tumor  cell  line  called  MDAY-D2,  is  restricted  to  local  growth  at  the  subcutaneous  site  of 
inoculation.  The WGN tumor cells  acquire  metastatic  ability  by fusing spontaneously with a 
normal  host cell followed  by chromosome  segregation,  a process  accompanied  by reversion 
of  the  WGN  phenotype  (i.e.,  WGAS). Since  lectin-resistant  mutant  cell  lines  often  have 
oligosaccharide  alterations  that  may affect  membrane  function  and  consequently  metastatic 
capacity, we compared the major Asn-linked glycopeptides in WGA  r and WGA  s cell lines.  [2- 
3H]mannose-labeled  glycopeptides  were separated  into  four  fractions  on  a  DEAE-cellulose 
column and then further fractionated  on a concanavalin  A-Sepharose column.  Glycopeptide 
structures were determined  by: (a) sequential  exoglycosidase  digestion  followed  by chroma- 
tography on  lectin/agarose  and  Bio-Gel  P-4 columns  and  (b) proton  nuclear  magnetic  reso- 
nance analysis. The metastatic WGA  s cells  had a sialylated  poly-N-acetyllactosamine-contain- 
ing  glycopeptide  which  was  absent  in  the  nonmetastatic  mutant  cell  line.  Unique  to  the 
mutant was a neutral triantennary class of glycopeptide  lacking sialic  acid and galactose;  the 
WGN lesion  therefore appeared to be a premature truncation of the antennae of the poly-N- 
acetyllactosamine-containing  glycopeptide found in the WGA  ~  cells.  High mannose glycopep- 
tides containing  five  to  nine  mannose  residues  constituted  a major class in  both  WGN and 
WGA  ~  cells.  Lysates of both wild-type and mutant cells  had similar levels of galactosyltransfer- 
ase activity capable of adding galactose  to the N-acetylglucosamine-terminated  glycopeptide 
isolated  from mutant cells;  the basis of the WGN lesion  remains  to be determined. 
Specific  changes  in  cell  surface  structures  have  long been 
associated with viral or chemical neoplastic transformation of 
mammalian cells (1); similar changes may also be required 
for benign tumor cells  to  acquire  malignant  (i.e.,  invasion 
and/or metastatic) properties (2-7). In particular, alterations 
in oligosaccharide structures of glycoproteins (2-5) and gly- 
colipids (6,  7) have been observed following both chemical 
and viral transformation. The asparagine-linked oligosaccha- 
rides of transformed cells appear to be larger due to increased 
terminal sialylation (2, 8) and in some cases due to increased 
branching (3).  Santer and  Glick (5)  found that chemically 
transformed hamster embryo cells initially had glycopeptides 
of the same  size  as the  normal  cell  counterpart.  However, 
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after being serially transplanted in animals (i.e., in vivo selec- 
tion for increased malignancy) the glycopeptides assumed a 
size profile similar to that of other malignant lines. The larger 
sialylated oligosaccharides may be more closely related to the 
acquisition of metastatic capacity than to the initial transfor- 
mation of the cell. Consistent with this interpretation are the 
results of Yogeeswaran  and  Salk (9) who showed that  the 
metastatic capacity of a  range  of murine  tumor cell  lines 
correlated with the degree of sialylation of available galactose 
and N-acetylgalactosamine residues on cell surface glycocon- 
jugates. 
The isolation of poorly metastatic tumor cell mutants from 
metastatic wild-type cells by selection in vitro for resistance 
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has added to the evidence that certain cell  surface oligosac- 
charides  are  conducive or even  necessary for expression  of 
the metastatic  phenotype.  WGA-resistant (WGA9  ~ mutants 
of the PG 19 melanoma (10), of the B 16 melanoma (11), and 
of the MDAY-D2 tumor line (12,  13) have all been shown to 
be less malignant than the respective parental tumor cell lines. 
Mutants selected with other lectins such as ricin I, leucoagglu- 
tinin  (PHA[L]),  and  concanavalin  A  (Con  A)  have  shown 
either no reductions in their metastatic potential  or even an 
increase  (14,  15).  These  observations  suggest  that  specific 
lesions in the  WGA-binding glycoconjugates of WGA  r mu- 
tants  may be  directly related to the decreased (11),  and for 
some types of mutants loss of, metastatic capacity (12). 
WGA  binds  most  avidly  to  oligosaccharides  containing 
sialic  acid  (16)  and  N-acetylglucosamine (17).  As might be 
expected,  many WGA  ~ mutants  have  under-sialylated  Asn- 
linked  glycoconjugates (18-20).  An  example  of this  is  the 
poorly metastatic WGA  r mutant of the B 16 melanoma called 
Wa-4 which has three to four times less cell surface sialic acid 
(19) and an increase in fucose linked al  ~  3 to N-acetylglu- 
cosamine (21).  Wa-4 has been  shown to have a  60-70-fold 
increase in a l-3-fucosyltransferase and it was suggested that 
competition between a l-3-fucosyltransferase and a2-3-sialyl- 
transferase  for Galf31-4GlcNAc-terminated  substrates  could 
result in the observed mutant oligosaccharide structures (22). 
Other structural  lesions  in  the  oligosaccharides of WGA  ~ 
cells  have been  described (23,  24) and  appear to be due to 
different lesions in the biosynthetic pathway for glycoconju- 
gates. Five genetic complementation groups ofWGA  ~  Chinese 
hamster  ovary (CHO)  cells  have  been  identified  (24),  each 
having  a  characteristic  phenotype  as  determined  by  cross- 
resistance to Con A, PHA(L), and ricin, and by WGA binding 
to  the  cell  surface  (18).  The  degree  of perturbation  of the 
metastatic  phenotype  observed  for any  tumor  cell  mutant 
selected for resistance to WGA may therefore depend on the 
specific oligosaccharide structures of the mutant in question. 
In this report, we examined the lesions in Asn-linked oli- 
gosaccharides of MDW40, a WGM mutant of MDAY-D (i.e., 
an  ouabain-resistant  subline  of  MDW4)  which  has  been 
shown to be  completely nonmetastatic  (12).  In preliminary 
experiments, MDW4 cells appeared to be less metastatic than 
MDAY-D2 as indicated by the survival times of mice injected 
subcutaneously with cells and the number of tumor nodules 
in  the  livers  of these  mice  (Fig.  1).  However,  upon  closer 
examination, the tumor cells in the organs of MDW4-injected 
mice were  found to be  revertant  for the  WGA  ~ phenotype 
(12), i.e.,  they had the following properties: they were WGA- 
sensitive (WGA~), retained the dominant genetic marker car- 
fled by the MDW4 subline W40T3 (i.e.,  ouabain resistance), 
had acquired 30-40 more chromosomes, had acquired host- 
derived  histocompatibility  markers  (i.e.,  when  DBA/2  F1 
hybrid hosts were used), and expressed the malignant pheno- 
type of MDAY-D2 when injected into a  new group of mice 
(25,  26).  These results  clearly demonstrated that the tumor 
cells in metastases of MDW4-injected mice were the progeny 
of a  host celI-MDW4 cell  hybrid. By fusing with a host cell, 
Abbreviations  used  in  this paper:  CHO,  Chinese hamster ovary; 
Con A,  concanavalin A;  endo-Cl,  endo-~3-N-acetylglucosaminadase 
CI; a-mG, methyla-D-glucopyranoside; NMR, nuclear magnetic res- 
onance;  PHA(L),  leucoagglutinin;  WGA  r,  wheat  germ  agglutinin- 
resistant; WGA  s, WGA-sensitive. 
the recessive WGA  r phenotype of MDW4 was suppressed and 
the hybrid acquired the metastatic phenotype. WGA  5 hybrid 
cells are a detectable minority of the tumor cell population at 
-30 d  after injection (26), become gradually dominant, and 
kill  the  mice  by  day  70.  Unlike  the  WGA  s  hybrids  and 
MDAY-D2 cells,  MDW4 does not give rise to experimental 
metastasis when less than  l0  s cells are injected intravenously 
(l 2), adding further support to the contention that the mutant 
is  nonmetastatic.  MDW4  is  however  tumorigenic  since  a 
small  dose (i.e.,  l02  cells)  will grow in  a  subcutaneous  site 
forming, 30 d  after injection, a  tumor mass with a diameter 
of-0.5 cm containing more than  10  s WGA  r MDW4 cells. 
The MDW4 mutant has previously been shown to have a 
three- to  fourfold reduction  in  cell  surface  sialic  acid.  Fur- 
thermore, the mutant cells attached more readily to fibronec- 
tin-  and  type  IV  collagen-coated  surfaces  than  the  WGA  s 
hybrids  or  MDAY-D2  (i.e.,  wild-type phenotype  for lectin 
resistance and metastasis)  (20). Neuraminidase treatment  of 
the WGA  s cell lines increased their attachment to the same 
substrates indicating a possible role for unsialylated glycocon- 
jugates in cell attachment which may in turn influence met- 
astatic  capacity.  As a  first  step  towards  identifying  specific 
glycoconjugates that may be involved in cell attachment and 
the malignant phenotype, we have compared the Asn-linked 
glycopeptides isolated  from  the  WGA  r  mutant  and  related 
WGA  s lines. 
MATERIALS  AND  METHODS 
Materials:  D-[2)H]mannose was  purchased  from  Amersham  Corp. 
(Oakville,  Ontario,  Canada)  and  UDP-N-acetyl-D-[U-t4C]glucosamine (300 
mCi/mmol) from New England Nuclear (Lachine, Quebec, Canada). Con A- 
Sepharose 4B was obtained  from Pharrnacia  Inc.  (Dorval, Quebec),  ricin  I/ 
agarose 120 from Miles Laboratories (Kankakee,  IL), and Bio-Gel P-2 (200- 
400 mesh), Bio-Gel P-4 (minus 400 mesh), Bio-Gel P-6 ( 100-200 mesh), Chelex 
100 (100-200 mesh), and AG I-X8 ( 100-200 mesh) from Bio-Rad Laboratories 
(Mississauga, Ontario). DE52, cellulose came from Whatman Laboratory Prod- 
ucts, Inc. (St. Louis, MO). Sigma Chemical Co. (St. Louis, MO) supplied Jack 
bean  /~-galactosidase, Jack  bean  /~-N-acetylglucosaminadase, UDP-galactose, 
and  UDP-N-acetylglucosamine.  Pronase  was purchased  from Calbiochem- 
Behring Corp. (Montreal, Quebec) and deuterium  oxide (99.96%) from Aldrich 
Chemical  Co.  (Milwaukee,  WI).  Endo-B-N-acetylglucosaminadase CI  from 
Clostridium perfringens (endo-Cl) was purified as previously described (27). 
Tumor Cell Lines:  The origin and properties of the highly metastatic 
DBA/2 strain tumor called MDAY-D2  has been described in detail (28, 29). 
The WGA  r nonmetastatic  mutant MDW4  was isolated from a  mutagenized 
population  of MDAY-D2  cells by selection  in  growth  medium  containing 
WGA as previously described (12). The ouabain-resistant  (3 mM) mutant of 
MDW4 called MDW40 was used for the isolation of  glycopeptides. The mutant 
had the same nonmetastatic  phenotype and cross-resistance pattern  to WGA, 
phytohemagglutinin, Con A, and ricin I as that of MDW4 (20). W40MI  was a 
line established  from a  liver  metastasis  in a  mouse that  had  been  injected 
subcutaneously with  l0  s MDW40 cells (i.e., tumor cell-host cell hybrid) (20). 
The cells were ouabain resistant, highly malignant, and had the same sensitivity 
to WGA, PHA(L), and Con A as did MDAY-D2 (Fig. 1). 
CIvcopeptide  Fractionation:  Tumor cells at a density  of 105/ml 
were grown for 24 h in Eagle's alpha  minimum essential medium plus  10% 
fetal calf serum. Duplicate 5-ml cultures received additions of 10 #Ci/ml of [2- 
3H]mannose and the cells were harvested 24 h later, washed, and pooled with 
1-5 x  109 unlabeled cells of the same lineage. The cold cells were gown in 6- 
liter spinner flasks in Eagle's alpha minimum essential medium plus 5% fetal 
calf serum and were harvested at subconfluent density (i.e., approximately  5 x 
105 cells/ml). The cells were extracted twice with 200 ml chloroform/methanol 
(2:1) (vol/vol) and the residue was taken up in 0. l M Tris HC1 (pH 7.9), 1 mM 
CaC12 and  digested  with  1%  (wt/wt) pronase  under toluene  as previously 
described (30). After  3 d  with daily additions  of pronase,  DNA,  RNA,  and 
glycosaminoglycans were precipitated with cetylpyridinium chloride (30). The 
glycopeptides were desalted  on a  Bio-Gel P-2 (200-400  mesh) column and 
again digested with pronase as above. After desalting on a Bio-Gel P-6 column 
(200-400  mesh), the samples were applied to a DE52 cellulose column ( 1 x 20 
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FIGURE  1  Summary of the  metastatic phenotypes  of  MDAY-D2, 
MDW40,  and  the  host  celI-MDW40  tumor  cell  hybrid  called 
W40M1  (25,  26).  Only  WGA-sensitive  hybrid  cells  are  found  in 
metastasis of MDW40-injected  mice (11).  Cells were grown in the 
presence of increasing concentrations of WGA for 24 h, then pulsed 
with [3H]thymidine to determine the WGA concentration necessary 
for 50% inhibition of DNA synthesis (D5o) (26). MDW4  had a Dso of 
50 ~g/ml for WGA,  80 #g/ml in  PHA(L),  9 ~g/ml in Con A, and 0.5 
ng/ml in ricin.  Both MDAY-D2  and W40M1  had Ds0 of 2/Lg/ml in 
WGA,  5 n.g/ml in  PHA(L),  32  ~g/ml in  Con A, and 0.5-2  ng/ml in 
ricin. 
cm). The columns were washed with 20 ml of 5 mM Tris HC1 (pH  7.0) and 
eluted with 150 ml of a linear gradient (0-50 mM NaCI) in a 5 mM Tris HCI, 
pH 7.0. 
Con  A]Sepharose and  Ricin  I/Agarose Chromatogra- 
phy:  Glycopeptides in 0.5 ml of water or less were applied to the columns 
(0.7 x  10 cm) of either Con A/Sepharose or ricin I/agarose equilibrated to 0.01 
M  Tris HCI, pH 7.5, containing 0.1  M  NaCl, at room temperature (31).  The 
columns were washed with 20-30 ml of buffer and 1-ml fractions were collected. 
The columns were then eluted with 20-30 ml of 0. l  M  methyl~-o-glucopyr- 
anoside (a-mG) for Con A/Sepharose and a-D-lactose for the ricin I/agarose 
column. For preparative columns, a  small aliquot of each  l-ml fraction was 
mixed with scintillation fluid and radioactivity was measured. Fractions  1-7 
(void  volume),  8-30  (retarded  peak),  and  fractions eluted  with  competing 
monosaccharide were pooled and designated A,  B, and  C,  respectively. For 
analytical experiments, -2,000 cpm were applied to a  column and the entire 
l-ml  fraction was used  for determination of radioactivity. The  recovery of 
radioactivity from the columns was 90-100%. 
GIycosidase Digestion:  Glycopeptide samples containing l0 nmol 
or less were digested with 0.05  U  of either Jack bean 8-galactosidase or Jack 
bean ~-N-acetylglucosaminadase or endo-CI in 200 ul of 0.1  M  phosphate/ 
citrate buffer, pH 5.0, at 37"C for 18 h under toluene. Sialic acid was removed 
from glycopeptides by incubating samples in 0.5 ml of 0. l  HCI at 80"C for  l 
h.  Samples were sized before and after glycosidase digestion on a  P-4 (minus 
400 mesh) l  x  I l0 cm column developed in 0.1 M  acetic acid. 
Nuclear Magnetic Resonance (NMR) Spectroscopy:  Trace 
metals were  removed  from  samples by  passage through  a  3-ml  column  of 
Chelex  100  which  had  been  extensively washed with  water.  Samples  were 
exchanged three times with 99.8%  deuterium oxide and dissolved in 99.96% 
deuterium oxide for analysis. The spectra were taken with a Nicolet 360-MHz 
spectrometer at the Toronto Biomedical NMR Centre (32). 
GIycosyItransferase Assays:  Tumor  cells  (20-30  x  106) were 
washed twice in 0.9%  NaCI, suspended in 2  ml of 0.2 M  NaCI, and freeze- 
thawed three times in an  ethanol/dry-ice bath.  The  cells were pelleted and 
washed three times in 0.9%  NaCI and  then solubilized in 0.9%  NaCI/0.5% 
Triton X-100. Hen oviduct membranes were prepared as previously described 
(33) and solubilized in 0.9% NaCl/0.5% Triton X-100. 
The incubation mixture for GlcNAc-transferases contained 20 nmol glyco- 
peptide,  5  #mol  2-(N-morpholino)ethane sulfonic acid,  0.5  umol  MnCl2,  8 
~mol GlcNAc, 26 nmol (130,000 dpm) UDP-N-acetyl o-[U-t4C]glucosamine, 
0.20 ~l Triton X-100, and 30-100 ug enzyme protein in a total volume of 40 
~l (34). GlcNAc-transferase I was assayed at pH 7.0 with ovalbumin glycopep- 
tide E, Mana 1-6(Mana l-3)Mana I-6(Mana l-3)Mant8 l-4GlcNAc-/~  l-4GcNAc- 
Asn (i.e., Man5).  GlcNAc-transferase II was assayed at pH  6.3 with Manal- 
6(GlcNAc~l - 2Mana I - 3)ManB1 - 4GlcNAcB1-4(Fuca I - 6)GIcNAc- Asn  (i.e., 
MGn) isolated from a human myeloma immunoglobulin G  as described (31). 
Branching GlcNAc-transferases (34) were assayed at pH 7.0 using GlcNAc~l- 
2Mana I - 6(GIcNAcB 1  - 2Mana 1  - 3)ManB I - 4GlcNAc/~ l - 4(Fuca I - 6)GIcNAc - 
Asn (i.e., GnGn). Biantennary glycopeptides are named according to the sugar 
residues at the nonreducing ends, the Manal-6  branch being named first; S 
denotes  sialic acid,  G  is  galactose,  Gn  is  N-acetylglucosamine, and  M  is 
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mannose. Samples were incubated for 30 and 60 min at 37"C and the reaction 
was terminated by the addition of  10 t~l of 2%  sodium tetraborate 0.25  M 
EDTA. Samples were applied to Whatman 3MM paper and subjected to high 
voltage electrophoresis in 1% sodium tetraborate. The paper was washed with 
80% ethanol by descending chromatography, dried, and cut into  l-cm pieces 
and radioactivity was measured. The glycopeptide products migrated 1-5 cm 
from the origin. 
The galactosyltransferase assay contained 20 nmol glycopeptide MGn  or 
GnGn, 5 #mol 2-(N-morpholino)ethane sulfonic acid, pH 7.4, 0.5 t~mol MnCI2, 
50 nmol (200,000 dpm) [U-t+C]galactose, 0.20 ~1 Triton X-100,  and 30-100 
ug enzyme proteins in a total volume of 50 ~1. Samples were incubated at 37"C 
for 1 h, diluted to 0.5 ml with cold H20, and applied to l-ml columns of AG1- 
X8. The columns were washed with 0.5 ml H20 and then twice with 1 ml H20. 
The  washes were  added  to  17  ml  of counting fluid and  radioactivity was 
measured. 
Glycopeptide  Standards:  Manal-6(Manal-3)Manal-6(GlcNAc- 
#l-2Manal-3)Man#l-4GlcNAc~l-4GlcNAc~l-Asn (i.e.,  GnlM5)  was  made 
from ovalbumin glycopeptide E by the action of purified hen oviduct GlcNAc- 
transferase I (33). The structure was confirmed by proton NMR analysis. MM 
glycopeptide Mana 1-6(Mana l-3)ManB I-4GIcNAc/~  1-4(Fuca l-6)GlcNAc-Asn 
was isolated from human myeloma immunoglobulin G, as previously  described 
(31).  Mana l-6(Manal-3)ManBI-4GlcNAc was made by digesting MM glyco- 
peptide with endo-CI. 
RESULTS 
Fractionation of GIycopeptides  from WGA r/ 
Nonmetastatic  and WGAS/Metastatic  Cells 
MDW40  cells are confined to growth at the subcutaneous 
site  of inoculation  where,  at  low  frequency,  bone  marrow- 
derived  host cells hybridize with  MDW40  cells (Fig.  1) (25). 
The WGA s hybrids display a selective growth advantage over 
the mutant cells at the site of injection and readily metastasize 
(i.e.,  W40M1).  This  transition  from a  nonmetastatic  tumor 
growth to a metastatic lesion in situ bears some similarities to 
the  phenomena  of  tumor  progression  described  for  other 
transplantable  tumors  (i.e.,  genetic  instability,  phenotypic 
heterogeneity, and selective outgrowth of the more malignant 
cells) (29).  Therefore we began by comparing the Asn-linked 
glycopeptide  from MDW40  and WGA s cells removed from a 
metastases in an MDW40-injected  mouse (i.e.,  W40M 1). 
Aliquots of MDW40  (WGA r, nonmetastatic) and W40M1 
cells  (WGA s,  metastatic)  grown  in  the  presence  of  2-[3H] - 
mannose were pooled with approximately  5  x  109 unlabeled 
cells of the same lineage, and glycopeptides were isolated from 
pronase  digests  of total  cell  proteins.  The  samples  were  de- 
salted  and  applied  to  a  DEAE-cellulose  column  to  separate 
neutral  and  sialylated  glycopeptides.  The  mutant  had previ- 
ously been shown to have three to four times less cell surface 
sialic acid (20) and, as expected,  MDW40  had relatively more 
neutral glycopeptides  (fraction  I,  Fig.  2)  than did  the WGA s 
cells.  W40M 1 glycopeptides  contained  a  fraction  IV (17.5% 
of the total) which  eluted  from the DEAE-cellulose  column 
near  the  end  of the  NaCI  gradient  and  was  not  found  in 
glycopeptides from MDW40  cells. 
Glycopeptides  separated  on DEAE-cellulose  were desalted 
and further fractionated on Con A/Sepharose columns. Non- 
bisected  biantennary  complex  and  high  mannose  glycopep- 
tides  are  known  to  bind  to  Con  A/Sepharose  and  may  be 
separated from tri- and tetra-antennary structures which pass 
unimpeded  through the column (31,  34).  The binding speci- 
ficities  of the  Con  A/Sepharose  used  in  these  experiments 
have been thoroughly characterized using standard glycopep- 
tides.  Biantennary oligosaccharides,  i.e.,  GX  or SX  (X  is M, 
Gn, G, or S), have been shown to bind weakly to the Con A/ 
Sepharose used in these experiments (31,  34); they elute from 
the column in a retarded fashion. High mannose (i.e.,  five to 400  - 
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FIGURE  2  DEAE-cellulose  chromatography  of  W40M1  (A)  and 
MDW40 (B) glycopeptides. ]-He [2-3HJmannose-labeled glycopep- 
tides from pronase digests of total cell proteins were applied to the 
column, and bound glycopeptides were eluted with a  linear NaCI 
gradient (start of gradient shown by arrow).  The four major peaks 
were pooled, desalted, and applied to Con A/Sepharose columns. 
nine mannose residues) and diantennary glycopeptides MX 
or GnX bind tightly to the column and can be eluted with 
0.1 M amG (31). Each of the four peaks separated on DEAE- 
cellulose  was  applied  to  a  Con  A/Sepharose  column  and 
separated  into  unbound  (A), retarded  (B), and  bound  (C) 
fractions (Table I). 
The  majority of the  neutral  glycopeptides from W40M1 
cells bound to Con A/Sepharose and only 4.6% of  this fraction 
was  unbound  (Fig.  3).  In  contrast,  34.2%  of the  neutral 
glycopeptides (25.2% of total) from MDW40 did not bind to 
Con A/Sepharose (fraction IA, Table I). The major difference 
between the lines was the increased amount of neutral Con 
A-unbound glycopeptide found in the mutant (Fig. 3) and the 
sialylated fraction IV found only in the WGA  s cells (Fig. 2). 
Structure of Fraction IA from WGA r Cells 
The glycopeptide fraction IA from mutant cells  appeared 
to have a  highly branched (more than two antennae) oligo- 
saccharide lacking terminal sialic  acid since it bound neither 
to  DEAE-cellulose  nor  to  Con  A/Sepharose.  Sialic  acid  is 
usually attached to galactose in complex structures. The sam- 
ple was therefore applied to a  ricin I/agarose column which 
retained standard glycopeptides with unsubstituted Gal resi- 
dues (Fig.  4A);  fraction  IA eluted  from the  ricin  I/agarose 
column in  the void volume. This suggested that the  nonre- 
ducing terminal residues of fraction IA may be N-acetylglu- 
cosamine and thus the fraction was treated with/3-N-acetyl- 
glucosaminidase followed by Con  A/Sepharose chromatog- 
raphy (Fig. 4 C). Most (85%) of  the previously Con A-negative 
fraction now bound tightly to the column and was eluted in 
a sharp peak with amG indicating that terminal N-acetylglu- 
cosamine residues had been removed to expose the triman- 
nosyl  core.  The  fl-N-acetylglucosaminadase-treated fraction 
IA was reduced in size but separated into three major peaks 
on a Bio-Gel P4 column (compare Fig. 4, B and D). The three 
peaks  were  pooled  and  digested  with  endoglycosidase  C1 
followed by chromatography on the Bio-Gel P4 column. The 
sample now eluted as a sharp peak coincident with authentic 
(Manal-6)Manal-3Manfil-4GlcNAc  (Fig.  4D).  This  indi- 
cated that the size heterogeneity in the fl-N-acetylglucosami- 
nadase-treated fraction IA was due to the peptide portion and 
not to incomplete glycosidase digestion. 
The  IH NMR spectra of the glycopeptides of fraction IA 
can only be tentatively interpreted at this time.  Because of 
the small amount of material, the best spectra were obtained 
at 70°C where the resonance from residual HDO obscures the 
fewest resonances; however, the data for reference compounds 
are limited at this temperature. Even with these problems, a 
number  of conclusions  can  be  drawn  which  support  the 
interpretation of the biochemical studies. Overall this fraction 
appeared to be a mixture of complex triantennary glycopep- 
tides  with  terminal  GIcNAc  residues.  Very  little  intensity 
appeared at  4.47-4.48  ppm where the  C1-H resonances of 
terminal Galfll-4 residues are found. However, a complex of 
two overlapping doublets (4.585 ppm, Y = 8.3 Hz; 4.561  ppm, 
J  =  8.8  Hz;  70°C)  was  found  with  N-acetyl resonances at 
2.078, 2.051,  2.049,  2.010 (70°C).  Although such resonances 
are not unique to unsubstituted GlcNAc, they are consistent 
with such residues being present. 
Furthermore, the branching pattern was difficult to assign 
with confidence.  Mannose C2-H corresponding to trianten- 
nary to tetra-antennary structures were present (4.215, 4.086 
ppm; 17°C) as were mannose C2-H resonances characteristic 
of biantennary and  triantennary (4.255,  4.188,  4.086  ppm; 
17°C) (35).  There was no evidence for bisecting GlcNAc. In 
view of  the failure of  this fraction to bind to Con A/Sepharose, 
the most consistent interpretation is that it represents a mix- 
ture of-33%  triantennary with the  Manal-3,  2,4 disubsti- 
TABLE  I 
Summary of Glycopeptide Separations  on DE52 Cellulose and 
Con AJSepharose 
DE52  Cel-  Con A/ 
lulose frac-  Sepharose 
tions  W40M1  MDW40  fractions  W40M1  MDW40 
% of total  % of total 
I  34.2  74.4  A  1.5  25.2* 
B  1.1  4.7 
C  31.6*  44.7* 
II  28.8  12.3  A  4.3  4.3 
B  3.6  0.9 
C  20.8  7.1 
III  19.5  13.3  A  8.4  2.8 
13  2.9  0.5 
C  8.2  10.0 
IV  17.5  0  A  14.9"  -- 
g  1.0  -- 
C  1.6  -- 
Separation of total on Con A[  A  27.1  32.3 
Sepharose  13  8.5  6.1 
C  63.2  61.9 
The separation of  [~H]mannose-labeled glycopeptides  from  W40M1 and 
MDW40 cells on DES2 cellulose (Fig.  2) and Con A/Sepharose  are compared. 
Each fraction  from the  DE52 cellulose column  was separated on  Con A/ 
Sepharose into excluded (A),  retarded  (B), and  bound  (C) fractions. The 
glycopeptide structures in the fractions marked with asterisks were further 
characterized. 
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tuted with G1cNAc and -66% triantennary with the Manal-
6, 2,6 disubstituted with G1cNAc (35).
W40M1 glycopeptides separated into four fractions on the
DEAE-cellulose column, fraction IV being the most nega-
tively charged species and found only in the WGA' cells (Fig.
2). Most of fraction IV did not bind to the Con A/Sepharose
column (Table I) suggesting that the glycopeptides had more
than two antennae on the trimannosyl core. Fraction IVA
(i.e., excluded from Con A/Sepharose) did not interact with
ricin I/agarose; removal of terminal sialic acid by mild HCl
treatment resulted in retardation by the ricincolumn indicat-
ing the presence ofsialyl-Galunits at the nonreducing termini
(Fig. 5). Treatment of sialic acid-free fraction IVA with ,B-
galactosidase only marginally reduced the size of the glyco-
peptide as observed by its elution position from a Bio-Gel P-
4 column (Fig. 6). If fraction IVA had the antennary structure
commonly found on many complex glycoproteins (i.e., sialyl-
Gal-GlcNAc), the removal of sialic acid and Gal residues
should reduce the size of the glycopeptide to approximately
that of the mutant G1cNAc-terminated fraction IA. This was
not the case since sialic acid-free, IB-galactosidase-treated frac-
B
FIGURE 3 Separation of the neutral glycopeptides
(fraction I) from W40M1 (A) and MDW40 (B) on a Con
A/Sepharose column. The unretarded, retarded, and
bound fractions were pooled, desalted, and subjected
to further analysis.
FIGURE 4 Structural analysis of glycopeptide frac-
tion IA. (A) An aliquot of fraction IA was applied to
a ricin I/agarose column and eluted as described in
the text. This ricin column has been shownto retard
the standard biantennary glycopeptide GG which
eluted without lactose in a broad peak centeringat
fraction 22. (B) The elution profile of fraction IA on
Bio-Gel P-4 (minus 400mesh). (C)Theelution profile
of ,B-N-acetylglucosaminidase-treated fraction IA on
ConA/Sepharose. (D)Theelution profiles of fraction
IA on Bio-Gel P-4 (minus 400 mesh) aftertreatment
with O-N-acetylglucosaminidase alone I(-) and
after both ,B-N-acetylglucosaminidase and endo-CI
(. ....). The elution positions of dextran blue, GnIM5,
MM, and endo-Cl-digested MM are indicated by
arrows, left to right, respectively, in B.
tion IVA eluted from Bio-Gel P-4 well ahead of fraction IA,
indicating that the antennae on fraction IVA were not sialyl-
Gal-GICNAc(Fig. 6).
Analysis of fraction IVA by 'H NMR revealed a signal at
4.747 ppm which is characteristic for the anomeric proton of
G1cNAc /71-3 linked to Gal and suggests a poly-N-acetyllac-
tosamine structure. The NMR spectra of fraction IVA made
at 70°C was compared with a 70°C spectra of the poly-N-
acetyllactosamine-containing complex isolated from CHO
cells as described by Li et al. (reference 36 and J. Carver,
manuscript in preparation). If repeating units of Gal/ll-
4G1cNAc#1-3 are present in the antennae of desialylated
fraction IVA, treatment with S-galactosidase followed by in-
activation of IB-galactosidase and treatment with fl-N-acetyl-
glucosaminadase would not reduce the glycopeptide to the
Con A-binding trimannosyl core. As expected, this sequential
glycosidase digestion yielded only 14% of material binding to
Con A/Sepharose; repetition of the sequential digestion re-
sulted in 40% Con A/Sepharose-bound material. When both
enzymes were present in the same incubation mixture, how-
ever, 60% of the radioactivity bound to Con A/Sepharose
(Fig. 7). The sample digested with both glycosidases simulta-
neously (Fig. 7 C) was analyzed on a Bio-Gel P-4 column and
48% of the material had the size expected for the trimannosylvo
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core glycopeptide (Fig. 6). The heterogeneity remaining after
glycosidase digestion may be due to fucosyl substitutions of
antennae which would block complete degradation to the
trimannosyl core (37). To summarize, fraction IVA from
W40M 1 cells contained sialylated poly-N-acetyllactosamine-
containing glycopeptides with intramolecular heterogeneity
due possibly to variations in the number of Galfll-
4G1cNAcfl1-3 repeating units and in substitution of the an-
tennae (Fig. 8).
We also examined the parental tumor line MDAY-D2 in
an effort to determine whether there was a possible relation-
ship between the presence of the sialylated poly-N-acetyllac-
tosamine-containing complex and metastatic behavior. Total
pronase digests of the W40M1 (data not shown) and the
parental tumor line MDAY-D2 (Fig. 9) separated on a Bio-
Gel P-6 column contained a large glycopeptide eluting in the
void volume. The MDAY-D2 sample was separated on DEAE
cellulose and analysis of fraction IV by NMR revealed a
spectra similar to that of W40M 1 fraction IVA including the
GlcNAc,6l-3Gal linkage (data not shown). Therefore re-
expression of the poly-N-acetyllactosamine-containing struc-
ture in the hybrid W40M 1 correlated with re-expression of
the metastatic phenotype in these cells.
High Mannose Glycopeptides of MDW40
and W40M1
The neutral Con A/Sepharose-bound glycopeptides in frac-
tion IC were a major component in both WGA' and WGAr
cells (i.e., 31.6 and 44.7% of W40M1 and MDW40, respec-
tively). Fraction IC from both MDW40 and W40M1 eluted
from the Bio Gel P-4 column in the same position as the
marker GnIM5 and had a G1cNAc/Asn ratio of approxi-
mately 2.5. An aliquot of fraction IC was subjected to ,B-N-
acetylglucosaminidaseand rechromatographedon the Bio Gel
P-4 column. The glycopeptides from W40M 1 were totally
resistant while a minor subfraction of the MDW40 sample
was reduced in size by the glycosidase treatment (data not
shown). The f-N-acetylglucosaminidase-resistant glycopep-
tides were the expected size for high mannose glycopeptides
containing five to nine mannose residues. The ,B-N-acetylglu-
cosaminidase-digestible subfraction present only in MDW40
fraction IC appeared to contain neutral nonbisected bianten-
nary complex glycopeptides with terminal G1cNAc residues.
The NMR spectra of MDW40 fraction IC shows signals at
4.55 and 4.57 ppm (Fig. 10) typical of antennary GIcNAc
residues.
The NMR spectra at 23° and 70°C of fraction IC from both
MDW40and W40M 1 cell lines(Fig. 10) contained resonances
B
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FIGURE 5 Binding of fraction IVA glycopeptides
from W40M1 cells to a ricin I/agarose column before
(A) and after (8) mild acid treatment. Fraction IVA
was incubated with 0.1 M HCI at 80°C for 1 h to
remove sialic acid. Proton NMR analysis before and
after HCI treatment confirmed the removal of a2-3-
linked sialic acid . Glycopeptides not retarded by the
ricin I/agarose were eluted in the first seven fractions
(7 ml) and galactose-terminated glycopeptides were
eluted by further washing with 0.01 M Tris, pH 7.5,
and 0.1 NaCl and with 0.1 M lactose in this buffer.
The standard glycopeptide GG eluted in a broad
peak centered at the position indicated by the un-
marked arrow in A.
Vo
oft-1
FIGURE 6 P-4 chromatography of mild acid-treated fraction IVA
glycopeptides from W40M 1 cells before and after digestion with 6-
galactosidase and ,B-N-acetylglucosaminadase. Aliquots ofthe HCI-
treated sample were applied to the P-4 (minus 400 mesh) column
before (O) and after (") digestion with tP-galactosidase, or with both
,B-galactosidase and 6-N-acetylglucosaminadase ("). Beginning at
the left, the arrows indicate the elution positions of dextran blue,
fraction IA from MOW40 cells, and GnIM5. After HCI treatment,
90% of fraction IVA was retarded on the ricin I/agarose column
(Fig. 5); after fl-galactosidase treatment of this sialic acid-free frac-
tion, only 27% of the radioactivity was retarded indicating that most
of the terminal galactose had been removed by the enzyme (data
not shown).
that can be assigned to a number of different microenviron-
ments (Table II). The resonances for the Man,Bl-4 and the
3,6 disubstituted Mana 1-6 were present as one equivalent per
molecule indicating that the smallest possible structure pres-
ent was the conventional Man5GlcNAc2Asn from ovalbumin.
If it is assumed that all possible, Mang, Man7, and Manb
isomers occur, then determination ofthe relative populations
is not possible. However, if it is assumed that the only
structures present are the postulated intermediates of high
mannose processing (38) as was found for CHO cells by Li
and Komfeld (39), then the individual species can be quan-
tified. Since the first mannose to be removed from Man9 in
the processing pathway is the 2-substituent on the Mana1-3
of the 6-arm, the integrated intensity of the resonance corre-
sponding to this microenvironment (-5.40 ppm, 23°C)quan-
tifies the Man9 species (-40% for MDW40 and W40M1).
The next residue to be removed is the 2-substituent of the
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1039Manal-2 of the 3-arm resulting in the loss of the resonance
characteristic of a Mana 1-2 ofthe 3-arm resulting in the loss
of the resonance characteristic of a Mana1-2-substituted
Manal-2 (-5.30 ppm, 23°C) . Therefore this resonance can
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FIGURE 7 Sequential removal of the repeating Gal-GIcNAc units
in the antennae of HCI-treated fraction ]VA. The sample was treated
with ,B-galactosidase, the enzyme was heat-inactivated at 100°C for
10 min, and then R-N-acetylglucosaminadase was added, digestion
was carried out, the enzyme was heat inactivated, the sample was
desalted, and half of the sample was separated on a Con A/
Sepharose column (A) . The remaining sample was digested again
with 0-galactosidase, heat inactivated, then incubated with O-N-
acetylglucosaminadase, heat inactivated, desalted, and applied to
the Con A/Sepharose column (8) . An aliquot of HCI-treated fraction
IV was also treated simultaneously with ,B-galactosidase and #-N-
acetylglucosaminadase, desalted, and separated on Con A/Sepha-
rose (C) .
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COMMON CORE STRUCTURE IN MDW40JW40M1
I
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G1 cNAc
be used to estimate the amount of (Man9 + Mane) present
and, by difference, Mang (15% for both cell lines) . Similarly
the resonance at 5.148 ppm (23°C) is characteristic of the
Martal-2-substituted Manal-6 of the 6-arm which is only
present in the Man 9 , Mang, and Man, species . Conversely,
the resonance at 4.917 ppm (70°C) is characteristic of an
unsubstituted Mana1-6 which only occurs in Man s and
Man s . Hence the population of Man, can be deduced and
was found to be 10-15% for both cell lines . The relative
populations ofMan s versus Mans can be estimated in several
ways. One method is to consider the intensity at -5.34 ppm
(at 23 °C) . All structures except Mans contribute one hydrogen
per molecule to this resonance since it corresponds to Mana 1-
3 residues al-2-substituted by either Man or Manal-2Man .
Thus the contribution of Mans can be calculated, knowing
those of Man9-7, or the population of Man s can be obtained
as the difference in intensity between this resonance and those
at -4.77 and -4.88 ppm (70°C), both of which arise from all
species. On this basis, both cell lines had about -20-30%
Man s and 10-15% Mans .
Of the structures considered to be present in this analysis,
the only G1cNAc-transferase I acceptor would be the Mans .
Therefore, by comparing fraction IC with Man s (ovalbumin
glycopeptide pool E) as substrates for purified hen oviduct
G1cNAc transferase I (41), an independent estimate of Man s
was obtained . Fraction IC from both MDW40 and W40M 1
accepted approximately three times less G1cNAc compared
with authentic Mans, suggesting that 75% of the glycopeptide
in fraction IC had substitutions blocking the addition of
FIGURE 9
￿
Pronase-digested aliquots of total ['H]mannose-labeled
glycopeptides from MDAY-D2 (A) and MDW40 (8) were fraction-
ated on a Bio-Gel P-6 column (2 x 90 cm) . The unmarked arrow
indicates the elution position ofGnGn . Vo is the void volume.
Man
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Complex oligosaccharide structures in mutant and wild-type tumor cells . Heterogeneity in the number of antennae
and in the number of GaI,Bl-4GIcNAc#1-3 repeats are likely . R = GIcNAcpt-4GIcNAc-Asn .B 
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FIGURE  10  The  360-MHz  ;H  NMR  spectra  at  70"C  of fraction  IC 
glycopeptides  from  W40MI  (A) and MDW40  (B). 
GlcNAc to the Manal-3  arm (i.e., Man6-9),  or as much as 
25% of fraction IC was Mans. 
To summarize, ~40% of the high mannose pools of both 
the WGA  r and the WGA  +  cells was Man9, with 25% of Mal~ 
and  15%  each of Mans,  ManT, and Mans.  Li and Kornfeld 
(39) found similar results  for CHO cells, ~36%  Mang, 27% 
Mans, and 36% Man6. 
Galactosyl- and 
N-Acetylglucosaminyl Transferases 
The glycopeptides in  fraction  IA from  mutant cells  and 
fraction IV from W40MI  cells  appeared to have a  similar 
GlcNAc-substituted trimannosyl core (Fig. 8).  The W40M1 
complex structure had  elongated poly-N-acetyllactosamine- 
containing antennae which were absent in the mutant struc- 
ture due to an apparent lack of galactose.  Galactosyltransfer- 
ase activities  in  cell lysates  of WGA  r and WGA  s cells were 
compared using MGn and GnGn as substrates  (Table  III). 
Mutant and wild-type cell lysates had similar activities and in 
addition there was no difference in galactosyltransferase  activ- 
ities when the GlcNAc-terminated fraction IA isolated  from 
MDW40 cells was used as acceptor. 
GlcNAc-transferases I and II (33) and GlcNAc-transferases 
III+ IV were measured using as substrates  Marts, MGn, and 
GnGn,  respectively.  GlcNAc-transferases I  (i.e., Mans)  was 
elevated  in  mutant  cell  lysates  while  the  other transferases 
were unchanged. Hen oviduct membrane is known to synthe- 
size GlcNAc-terminated oligosaccharides  of a type very sim- 
ilar  to  those  in  fraction  IA (40).  It is  interesting  that  hen 
oviduct membrane had  a  high GlcNAc-transferase I and  a 
low Gal-transferase (with MGn) activity when compared with 
the tumor cells (Table III). The relative proportion of  GlcNAc- 
to galactosyltransferases  may regulate  the early termination 
of antennae in hen oviduct but this does not appear to be the 
case for MDW40 cells. 
TABLE  II 
Chemical Shifts for the High Mannose Glycopeptide Pool from W4OM1 and MDW40 Cells* 
Man  t 
Microenvironment*  W40M1  MDW40  £*  Shift*  9  8  7  6  5 
Mana 1-2 Mana 1-3  5.373  5.369 
(6-arm)  5.406  5.409  16  5.404  +  .... 
(_Manal-2)Mana1-2Manal-3  5.332  5.331 
(3-arm)  5.341  5.343  3, 4  5.34-5.35  +  +  +  +  - 
Man~1-2Manal-2  5.283  5.282 
5.309  5.309  1  5.304  +  +  -  -  - 
Mana1-2Manal-6  5.118  5.117 
5.148  5.148  39  5.144  +  +  +  -  - 
Man, l-3  5.118  5.117 
5.084  5.086  10  5.089  -  +  +  +  + 
Manal-2  5.058  5.057 
5.040  5.042  2  5.049  +  +  +  +  - 
Mana 1-6  4.917  4.915 
4.905  I  41  4.909  -  -  -  +  + 
Mana1-3(Manal-6)Mana  1-6  4.880  4.878 
4.866  --I  37  4.872  +  +  +  +  + 
Manc~1-3(Manal-6)Manl~l-4  4.765  4.763 
4.771  I  19, 20  4.78  +  +  +  +  + 
* For each microenvironment the upper line gives the chemical shift at 70"C, the lower line that obtained at 23"C. 
* The  chemical  shifts  are  the  C1-H  resonance  of  the  residue  italicized.  "£"  and  the  "shift"  refer  to  the  designation  and  mean  chemical  shift  for  that 
microenvironment as given in Carver and Grey (40). 
! These  columns indicate whether the rnicroenvironment is present (+) in the structures  with the number of mannoses  indicated by the corresponding column 
heading. 
I Signal obscured by residual  HDO signal. 
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Glycosyltransferase Activities in Tumor Cell Lysates and in Hen 
Oviduct  Membranes 
GIcNAc Transferase 
Substrate  Man5 MGn  GnGn 
Gal Transferase 
MDW40 
fraction 
MGn  GnGn  IA 
nmol]mg per h 
Tissue 
MDAY-D2  8.1  10.3  2.8  8.8  20.7  25.4 
MDW40  18.6  11.8  1.9  5.1  23.1  23.3 
HOM  16.4  11.1  9.6  3.2  7.6  ND 
GIcNAc  and  galactosyl-transferase  activities  in  tumor  cell  lysates  and  hen 
oviduct  membranes  (HOM)  were  assayed  as  described  in  Materials  and 
Methods. The substrates  were added at 20 nmol/assay  except for MDW40 
fraction IA where 5 nmol was used. ND, not determined. 
DISCUSSION 
WGA  r mutants selected from the MDAY-D2 tumor line (12, 
13), the BI6 melanoma (11), and PG 19 melanoma (10) have 
been shown to be less malignant or nonmetastatic compared 
with  the  respective parental  line,  but  selection  with  other 
lectins  has  not  resulted  in  the  isolation  of nonmetastatic 
mutants (14,  15). Many lectin-resistant cell lines have lesions 
in cell surface oligosaccharide structures and it is possible that 
specific changes  found  most  often  in  mutants  selected  in 
WGA lead to a decrease in matastatic capacity. 
Many WGA mutants of CHO cells (23,  24) and of tumor 
lines (18-20) including MDW40 have less cell surface sialic 
acid than the parental lines, which may be related to decreased 
malignancy since  the  degree of sialylation  of available cell 
surface galactose and N-acetylgalactosamine has been shown 
to correlate with metastatic capacity (9). Sialylation of tumor 
cell glycoconjugates has been shown to correlate with platelet 
aggregation activity (42),  inversely with tumor cell suscepti- 
bility to natural killer cell lysis (43), and inversely with tumor 
cell adhesion to the extracellular matrix proteins fibronectin 
and collagen type IV (20).  Each of these membrane-related 
properties  of the  tumor  cell  has  been  suggested  to  be  an 
important feature of the metastatic phenotype (1). Simply the 
presence or absence of sialic  acid may affect certain  mem- 
brane functions or, more likely, both sialic acid and underly- 
ing  oligosaccharide  structures  are  involved.  The  galactose 
receptor on  hepatocytes provides an  example of the  latter. 
The receptor binds to oligosaccharides terminating in galac- 
Lose (mono =  << bi =  << triantennary) but not to the same 
oligosaccharide with  terminal  sialic  acid  (44).  In  a  similar 
manner, glycoconjugates lacking sialic  acid may be involved 
in membrane binding interactions such as tumor cell recog- 
nition  by natural  killer cells  and  tumor cell  attachment to 
extracellular matrix proteins. 
We have compared the Asn-linked glycopeptides isolated 
from the total cellular protein of the  nonmetastatic mutant 
MDW40  and  the  in  vivo  derived  metastatic  revertant, 
W40MI.  Approximately  40%  of the  [3H]mannose-labeled 
glycopeptides from both mutant and wild-type cells were high 
mannose structures with five to nine mannose residues. Pro- 
ton NMR analysis revealed that this class of glycopeptide was 
very similar in MDW40 and W40M 1 cells.  However, glyco- 
peptides bearing complex oligosaccharides were dissimilar in 
mutant and wild-type cells. A large fraction of the glycopep- 
tides found in  MDW40  cells was shown to be triantennary 
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with a  single  GlcNAc as the antenna.  Further substitutions 
on  the  antennae  appeared to  have produced  the  sialylated 
poly-N-acetyllactosamine-containing  glycopeptides  found 
only in wild-type cells  (i.e.,  W40M1  and  MDAY-D2).  Loss 
of the metastatic phenotype in the mutant was accompanied 
by the loss of the  sialylated poly-N-acetyllactosamine struc- 
ture. This relationship is strengthened by the finding that re- 
expression of the  structure  in  the  hybrid line  W40M1  was 
accompanied by reacquisition of the metastatic phenotype. 
Since  the  complex  oligosaccharides  from  MDW40  cells 
terminated in GlcNAc, synthesis in the mutant appeared to 
be inhibited at the point of galactose addition.  However, the 
mutant and  wild-type cells  had  similar levels of galactosyl- 
transferase capable of adding Gal to GnGn, MGn, and, most 
importantly, to the mutant structures in fraction IA. MDW40 
cells thus appear to have both galactosyltransferase and suit- 
able oligosaccharide acceptor for the enzyme, but due to either 
a deficiency of UDP-galactose or to an error in compartmen- 
talization of the enzyme and substrates, the transfer of galac- 
Lose to fraction IA oligosaccharides does not occur in  vivo. 
The  twofold  increase  in  GlcNAc-transferase  I  activity  in 
MDW40 cells does not in any obvious way account for the 
observed oligosaccharide structures in the cells. The action of 
GlcNAc-transferase I commits the oligosaccharides to hybrid 
and complex structures (45). 
Clone  13,  a WGA  r CHO mutant, appears to have a  phe- 
notype similar to that of MDW40 (46).  The mutant did not 
incorporate  galactose  into  either  glycolipids or  Asn-linked 
oligosaccharides and this defect could not be attributed to a 
change in  galactosyltransferase levels,  UDP-galactose pools, 
or  endogenous galactose acceptors.  Clone  13  produces  the 
galactose-containing tetrasaccharides sequence found in gly- 
cosaminoglycans, which  is  synthesized  in  the  endoplasmic 
reticulum rather than in the Golgi complex where galactose 
is added to the antenni  of Asn-linked oligosaccharides (47). 
Consequently, Briles  (47)  has suggested that a Golgi-specific 
defect involving compartmentalization of UDP-galactose or 
galactosyitransferase may be responsible for the defect in clone 
13. 
MDW40 cells were found to be  10-fold  more sensitive to 
the  cytotoxic effect of the  terminal GlcNAc-binding  lectin 
from Bandeiroea  sirnplificifolia  seeds (BSII) than were wild- 
type cells (data not shown).  Therefore, MDW40  appears to 
express  the  mutant  GIcNAc  terminating  complex  on  the 
surface of the cell. 
Amino acid heterogeneity remaining after exhaustive pro- 
nase digestion made glycopeptide sizing on the Bio-Gel P-4 
column difficult as was evident from the analysis of fraction 
IA (Fig.  4).  After endo-C1 digestion of ~-N-acetylglucosami- 
nadase-treated fraction IA, the sample eluted from the Bio- 
Gel  P-4  column  as  a  sharp  peak coincident  with  Mana l- 
6(Manal-3)Man~l-4GlcNAc. Amino acid heterogeneity also 
complicated the  analysis of glycopeptide fraction II and  III 
from the DE52 cellulose column. After mild acid treatment 
the majority of the glycopeptide in fractions II and III were 
again retained on DE52 cellulose suggesting that the negative 
change  resided  in  the  peptide portion  rather than terminal 
sialic acid (data not shown). Therefore fraction II and III were 
not analyzed further. Separation problems created by hetero- 
geneity  in  the  peptide  portion  of the  glycopeptide will  be 
eliminated in  our subsequent  studies by releasing the  Asn- 
linked  oligosaccharides  with  peptide  N-glycosidase isolated 
from almond emulsin. The sialylated glycopeptide found in the metastatic WGA  s 
cells but not in the mutant contained repeating units of Gal- 
GlcNAc as has been reported for Asn-linked oligosaccharides 
isolated  from erthrocyte glycoproteins (48),  K562  leukemia 
(49),  and rat erthroleukemic cell lines (50).  The inability of 
/3-galactosidase plus ~-N-acetylglucosaminadase to completely 
digest fraction IVA to MM suggests that there may be branch- 
ing of the antennae similar to that reported for other poly-N- 
acetyllactosamine-containing glycopeptides (37, 49). Some of 
the Gal residues in the antennae have been reported to have 
either Fuca 1-2 (37) or Galfl 1-4GlcNAc/31-6 substitutions (49). 
Proton NMR analysis of  fraction IV indicated an a2-3 linkage 
for terminal  sialic acid (16), but more detailed  analysis was 
not possible because of the considerable heterogeneity of this 
fraction. 
Melanoma cells and fibroblasts treated with tunicamycin, 
an inhibitor of Asn-linked carbohydrate synthesis have been 
shown to be less adhesix, e to fibronectin-coated surfaces (51, 
52). In addition, some ricin-resistant baby hamster kidney cell 
lines  with  lesions  in  oligosaccharide  structure  have  been 
shown to be less adhesive on fibronectin (53). The decreased 
sialylation of the Asn-linked oligosaccharide of MDW40 has 
previously been implicated in the more adhesive behavior of 
the cells on fibronectin and type IV collagen (20), a  charac- 
teristic of the cell line that may inhibit their escape from the 
primary subcutaneous site. 
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